{'fraction_non_alphanumeric': 0.020884520884520884, 'fraction_numerical': 0.0012285012285012285, 'mean_word_length': 5.735537190082645, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Effects of cisplatin on testicular functions in rats.

In adult male rats serum levels of FSH, LH and testosterone were determined following treatment with cisplatin [cis-diamminedichloroplatinum(II)] for 3 alternate days, in order to study the effects of cisplatin on pituitary-testicular axis and subsequent effects on spermatogenesis. The decreased levels of testosterone with elevated FSH and LH levels in CDDP-treated rats are indicative of intact pituitary-testicular axis. The quantitation of spermatogenesis by flow cytometric analysis revealed that various germ cell populations and kinetics of spermatogenesis remain unchanged in CDDP-treated rats. Thus, CDDP treatment has been shown to decrease testosterone production in the testis without affecting the functional status of spermatogenic compartment.